- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Folate Receptor Alpha Positive
Total 349 results
-
Fudan UniversityNot yet recruitingHormone Receptor-positive Advanced Breast Cancer
-
Memorial Sloan Kettering Cancer CenterRecruitingHormone Receptor Positive Metastatic Breast CancerUnited States
-
Duke UniversityUnited States Department of DefenseCompletedHealthy | Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
University of California, San FranciscoDana-Farber Cancer Institute; Translational Breast Cancer Research ConsortiumCompletedMetastatic Breast Cancer | Hormone Receptor PositiveUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityUnknownEstrogen Receptor-positive Breast Cancer | FulvestrantChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
Gencurix, Inc.RecruitingEarly Hormone Receptor-positive Breast CancerKorea, Republic of
-
Novartis PharmaceuticalsCompletedOestrogen Receptor Positive Advanced Breast CancerUnited Kingdom
-
Fudan UniversityRecruitingBreast Cancer | Breast Neoplasm | Breast Tumors | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer | Triple-Negative Breast Cancer (TNBC)China
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive | Male Breast CarcinomaUnited States
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, India, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Guatemala, H...
-
Seoul National University HospitalActive, not recruitingHormone Receptor-positive Breast Cancer | Premenopausal Breast CancerKorea, Republic of
-
Seoul National University HospitalActive, not recruitingInvasive Breast Cancer | Estrogen Receptor Positive Breast CancerKorea, Republic of
-
Loyola UniversityCompletedMetastatic Breast Cancer | Estrogen Receptor Positive | Adult WomenUnited States
-
Cairo UniversityUnknownBreast Cancer | Metastatic Breast Cancer | Estrogen Receptor-positive Breast CancerEgypt
-
National Taiwan University HospitalRecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone TherapyTaiwan
-
Novartis PharmaceuticalsActive, not recruitingSomatostatin Receptor-positive Neuroendocrine TumorJapan
-
Abramson Cancer Center of the University of PennsylvaniaCompletedEstrogen-receptor Positive Invasive Metastatic Breast CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
University of Wisconsin, MadisonNot yet recruitingNeuroendocrine Tumors | Somatostatin Receptor-positive Neuroendocrine TumorUnited States
-
British Columbia Cancer AgencyCanadian Cancer Society (CCS); NanoString Technologies, Inc.Active, not recruitingBreast Cancer Female | Hormone Receptor Positive TumorCanada
-
UNICANCERBreast International GroupCompletedBreast Cancer | Menopause | Estrogen Receptor Positive Tumor | Hormone AntagonistFrance, Sweden, Spain
-
University of California, IrvineEli Lilly and CompanyTerminatedBreast Neoplasm | Hormone Receptor Positive Breast CarcinomaUnited States
-
Sunnybrook Health Sciences CentreGenomic Health®, Inc.CompletedHormone Receptor Positive Malignant Neoplasm of BreastCanada
-
Laura M. Spring, MDMerck Sharp & Dohme LLC; Translational Breast Cancer Research Consortium; Breast...RecruitingTriple Negative Breast Cancer | Hormone Receptor Positive (HR+), HER2-negative Breast Cancer | Biopsy-proven, Positive Lymph Node(s)United States
-
Dana-Farber Cancer InstituteJohns Hopkins University; Translational Breast Cancer Research ConsortiumNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Stage IV Breast Cancer | Breast Cancer Female | Breast Cancer Metastatic | Estrogen Receptor-positive Breast CancerUnited States
-
St Vincent's HospitalRecruitingHormone Receptor Positive Tumor | Early-stage Breast CancerAustralia
-
Georgetown UniversityTyme, IncTerminatedBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Breast CarcinomaUnited States
-
Georgetown UniversityUniversity of Chicago; Thomas Jefferson UniversityCompletedHormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | Hormone Receptor Positive TumorSweden
-
Eli Lilly and CompanyCompletedBreast Cancer | Early-Stage Breast Carcinoma | Hormone Receptor Positive TumorUnited States, Canada, Korea, Republic of, Italy, Austria, Belgium, Germany, Netherlands, Spain, Taiwan
-
Yale UniversityCompletedBreast Cancer | Early Stage Estrogen Receptor (ER) Positive Breast CancerUnited States
-
Fudan UniversityRecruitingHormone Receptor Positive HER-2 Negative Breast CancerChina
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital UlmRecruitingHormone Receptor Positive HER-2 Negative Breast CancerGermany
-
Grupo LusófonaFundação para a Ciência e a Tecnologia; Faculdade de Motricidade HumanaRecruitingBreast Cancer Female | Hormone-receptor-positive Breast CancerPortugal
-
National Cancer Centre, SingaporeMSD Pharma (Singapore) Pte LtdRecruitingHormone Receptor-Positive HER2-Negative Advanced Breast CancerSingapore
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive, HER2-negative, Advanced Breast CancerJapan, Hong Kong, Singapore
-
German Breast GroupNovartisCompletedBreast Cancer | Hormone Receptor Positive TumorGermany
-
University of Wisconsin, MadisonMillennium Pharmaceuticals, Inc.CompletedPost Menopausal, Hormone Receptor Positive Breast CancerUnited States
-
BiocadCompletedHuman Epithelial Receptor (HER)-2 Positive Breast CancerUkraine, Russian Federation, Belarus, India
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnObesity | Stage I Uterine Corpus Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive | Stage IA Uterine Corpus Cancer | Stage IB Uterine Corpus CancerUnited States
-
Jonsson Comprehensive Cancer CenterTranslational Research in OncologyCompletedStage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Oral Complications | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Fundacion CRIS de Investigación para Vencer el...Bayer; Pfizer; Apices Soluciones S.L.CompletedHormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer MetastaticSpain
-
University of WashingtonBreast Cancer Research FoundationNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma | Locally Advanced Unresectable HER2-Negative Breast Carcinoma | Locally Advanced Unresectable Hormone Receptor-Positive...United States
-
Osaka Medical CollegeTerminatedBreast Cancer | HER-2 Positive Breast Cancer | Estrogen Receptor Negative NeoplasmJapan
-
Seoul National University HospitalCompletedHormone Receptor Positive Malignant Neoplasm of BreastKorea, Republic of
-
GlaxoSmithKlineWithdrawnHormone-receptor Positive Breast CancerUnited States
-
Organisation for Oncology and Translational ResearchUnknownHormone Receptor Positive Malignant Neoplasm of BreastChina
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.RecruitingBreast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerGermany
-
Inova Health Care ServicesCity of Hope Medical CenterRecruitingBreast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States